David M. Goldenberg is a physician-scientist and philanthropist who conducted cancer research for more than 50 years. He is the found of Immunomedics, Inc., a biotechnology company developing monoclonal antibodies.He studied human olfaction during his graduate school studies in Germany. He holds a B.S. from the University of Chicago.
